Cargando…
A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer
Pancreatic cancer is a lethal malignancy with a 5-year survival rate of about 10% in the United States, and it is becoming an increasingly prominent cause of cancer death. Among pancreatic cancer patients, pancreatic ductal adenocarcinoma (PDAC) accounts for more than 90% of all cases and has a very...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716208/ https://www.ncbi.nlm.nih.gov/pubmed/36465388 http://dx.doi.org/10.3389/fonc.2022.1052132 |